Drug Formulation, Solubility and Bioavailability Summit

The Latest Formulation and Delivery Strategies to Reduce Testing Time, Improve the Patient Experience, and Accelerate Time to Market

Boston, MA, United States

While still facing evergreen problems with API solubility, formulation professionals are finding new areas for growth in immuno-oncology, regenerative therapies, and controlled release delivery.  And beyond purely technical questions, in an increasingly connected workplace the need for improved teamwork is stronger than ever.

Our 8th Drug Formulation, Solubility & Bioavailability conference is a unique strategic forum where R&D professionals gather to review and rank the latest technological options for drug formulation and delivery, while also bridging the gaps of understanding that may exist between team members.

Top Five Reasons to Attend

  1. Focus on stronger teamwork between formulation and medicinal chemistry
  2. New insights on continuous manufacturing during early development
  3. Improved drug delivery options for immuno-oncology and regenerative medicines
  4. Innovative CNS delivery methods across the blood-brain barrier
  5. Strategies to select the least painful drug delivery methods

Who Should Attend

Pharmaceutical, biotech and medical device professionals responsible for the following areas:
  • Formulation / Preformulation
  • Pharmaceutical Development
  • Preclinical Development
  • Pharmacokinetics / Pharmacodynamics / PKDM / DMPK
  • Pharmaceutics / Biopharmaceutics
  • Physicochemistry
  • Solid State Characterization
  • Drug Delivery
  • Drug Discovery
  • Analytical Development
  • Medicinal Chemistry
  • Material Science
  • Toxicology
  • Chemical Engineering
  • Product Development
This conference will also be of interest to:
  • Formulation / Solubility Specialists
  • Drug Delivery Specialists
  • Excipient Manufacturers / Suppliers
  • API Manufacturers / Suppliers
  • Modeling Software Specialists
  • CMOs
  • CDMOs
  • Central Labs


  • Kang-Jye Chou, Scientist, GENENTECH
  • David Cipolla, Vice President, Research, INSMED
  • Ann Daugherty, Senior Manager, Drug Delivery, GENENTECH
  • Eric Dinarello, Senior Scientific Associate, VERTEX PHARMACEUTICALS
  • Helen Hao Hou, Senior Scientist, Small Molecule Pharmaceutical Sciences, GENENTECH
  • Keith Horspool, Vice President, Pharmaceutics, BOEHRINGER INGELHEIM
  • Hyungchul Kim, Fellow, NOVARTIS
  • Wei Li, Postdoctoral Fellow, Laboratory for Drug Delivery, GEORGIA INSTITUTE OF TECHNOLOGY
  • Craig McKelvey, Specialty Dosage Formulation Group Lead, MERCK
  • Eric Munson, Professor and Head, Department of Industrial and Physical Pharmacy, PURDUE UNIVERSITY
  • Rashmi Nair, Formulation Scientist, DR. REDDY’S
  • Katharine Odneal, Senior Formulation Scientist, Research and Development, NESHER
  • Dhaval Patel, Senior Research Investigator, BRISTOL-MYERS SQUIBB
  • Robert Prud'homme, Professor, Chemical and Biological Engineering, PRINCETON UNIVERSITY
  • Aliasger Salem, Head, Division of Pharmaceutics and Translational Therapeutics, UNIVERSITY OF IOWA
  • Manuel Sanchez-Felix, Senior Fellow, Formulation, NOVARTIS
  • Jerome Schentag, CSO, VOLANT PHARMA
  • Wei Xu, Director, Preformulation, MERCK
  • Tao Zhang, Principal Scientist, Drug Product Design, PFIZER


Revere Hotel Boston Common
200 Stuart Street
Boston, MA 02116

Shaped by the local culture and rebellious, independent spirit fueling Boston since its founding, Revere Hotel Boston Common is a place of unexpected discoveries. Balconies look out over the city skyline and Back Bay, local artwork adorns the walls, and authentic New England cuisine tempts you.

To make reservations over the phone, please call 1-855-673-8373 and request the negotiated rate for ExL's 8th Bioavailability. To make reservations online CLICK HERE

You must book your room by March 4, 2019 in order to receive the group rate. Please book your room early, as rooms available at this rate are limited.
Event details
Organizer : ExL Events
Venue : Revere Hotel Boston Common, Boston, MA, United States
Event type : Conference
Reference : ASDE-19174